Focal adhesion alterations in G0-positive melanoma cells

Area of Science:

• Oncology
• Cell Biology
• Pharmacology

Background:

• Melanoma exhibits significant heterogeneity and drug resistance.
• Therapeutic drugs can induce cancer cell transition to the G0 phase, potentially leading to tumor dissemination.
• Understanding dacarbazine's effect on melanoma cell cycle is crucial for chemoresistance research.

Purpose of the Study:

• To investigate dacarbazine's ability to induce G0 phase transition in melanoma cells.
• To identify mechanisms of chemoresistance related to dacarbazine treatment.
• To analyze gene expression and cellular changes associated with dacarbazine-induced G0 phase.

Main Methods:

• Flow cytometry to analyze cell cycle distribution and G0-positive cells.
• Transcriptome profiling to identify genes related to dacarbazine resistance.
• Assays for beta-galactosidase activity, cell adhesion, and dacarbazine metabolism (CYP enzymes).

Main Results:

• Dacarbazine treatment increased the percentage of melanoma cells in the G0 phase without affecting senescent cells.
• Transcriptomic analysis revealed enrichment of 'VEGFA-VEGFR2 signaling pathway' and 'Cell cycle' signaling.
• Dacarbazine triggered 'Focal adhesion' signaling and increased G0-positive cells among adherent melanoma cells.

Conclusions:

• Dacarbazine alters the percentage of melanoma cells in the G0 phase, contributing to chemoresistance.
• The altered adhesive phenotype in G0-phase melanoma cells suggests a unique intercellular communication pattern for quiescent/senescent cells.